161 related articles for article (PubMed ID: 19789342)
1. Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells.
Hong B; Ren W; Song XT; Evel-Kabler K; Chen SY; Huang XF
Cancer Res; 2009 Oct; 69(20):8076-84. PubMed ID: 19789342
[TBL] [Abstract][Full Text] [Related]
2. Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.
Subramanya S; Armant M; Salkowitz JR; Nyakeriga AM; Haridas V; Hasan M; Bansal A; Goepfert PA; Wynn KK; Ladell K; Price DA; N M; Kan-Mitchell J; Shankar P
Mol Ther; 2010 Nov; 18(11):2028-37. PubMed ID: 20648001
[TBL] [Abstract][Full Text] [Related]
3. A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen-specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells.
Wang Y; Wang S; Ding Y; Ye Y; Xu Y; He H; Li Q; Mi Y; Guo C; Lin Z; Liu T; Zhang Y; Chen Y; Yan J
Clin Vaccine Immunol; 2013 Sep; 20(9):1449-56. PubMed ID: 23885028
[TBL] [Abstract][Full Text] [Related]
4. Effects of epidermal growth factor receptor fusion protein on the cytotoxic activity of SOCS1-silenced dendritic cells in vitro.
Jiang Q; Wang X; Qian M; Chen D; Xu Y
Oncol Rep; 2018 Mar; 39(3):1306-1312. PubMed ID: 29286121
[TBL] [Abstract][Full Text] [Related]
5. Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.
Shi D; Li D; Yin Q; Qiu Y; Yan H; Shen Y; Lu G; Liu W
Immunol Res; 2015 Mar; 61(3):206-18. PubMed ID: 25381480
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
[TBL] [Abstract][Full Text] [Related]
7. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
Song XT; Evel-Kabler K; Rollins L; Aldrich M; Gao F; Huang XF; Chen SY
PLoS Med; 2006 Jan; 3(1):e11. PubMed ID: 16381597
[TBL] [Abstract][Full Text] [Related]
8. Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector.
Zhou H; Zhang D; Wang Y; Dai M; Zhang L; Liu W; Liu D; Tan H; Huang Z
Biochem Biophys Res Commun; 2006 Aug; 347(1):200-7. PubMed ID: 16815301
[TBL] [Abstract][Full Text] [Related]
9. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
[TBL] [Abstract][Full Text] [Related]
10. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
12. Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene.
Hanada T; Tanaka K; Matsumura Y; Yamauchi M; Nishinakamura H; Aburatani H; Mashima R; Kubo M; Kobayashi T; Yoshimura A
J Immunol; 2005 Apr; 174(7):4325-32. PubMed ID: 15778397
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.
Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ
Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466
[TBL] [Abstract][Full Text] [Related]
14. [Silencing of SOCS1 and IL-12 gene cotransferred by adenoviral enhances DC-mediated anti-laryngocarcinoma immunity in vitro].
Li Y; Yuan Y; Wang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(19):890-2, 896. PubMed ID: 23285955
[TBL] [Abstract][Full Text] [Related]
15. Late dendritic cells are still able to evoke a potent alloreactive CTL response.
Repnik U; Bergant M; Wraber B; Jeras M
Immunobiology; 2008; 213(1):51-64. PubMed ID: 18207027
[TBL] [Abstract][Full Text] [Related]
16. [Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].
Wang Z; You H; Song S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):379-83. PubMed ID: 23643168
[TBL] [Abstract][Full Text] [Related]
17. Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.
Kumar J; Kale V; Limaye L
Stem Cell Res Ther; 2015 Sep; 6():184. PubMed ID: 26407613
[TBL] [Abstract][Full Text] [Related]
18. Egr2 induced during DC development acts as an intrinsic negative regulator of DC immunogenicity.
Miah MA; Byeon SE; Ahmed MS; Yoon CH; Ha SJ; Bae YS
Eur J Immunol; 2013 Sep; 43(9):2484-96. PubMed ID: 23716134
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling 2 is a feedback inhibitor of TLR-induced activation in human monocyte-derived dendritic cells.
Posselt G; Schwarz H; Duschl A; Horejs-Hoeck J
J Immunol; 2011 Sep; 187(6):2875-84. PubMed ID: 21844389
[TBL] [Abstract][Full Text] [Related]
20. SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.
Evel-Kabler K; Song XT; Aldrich M; Huang XF; Chen SY
J Clin Invest; 2006 Jan; 116(1):90-100. PubMed ID: 16357940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]